Samantha McStocker

Reduction in Health Care-Related Costs After Initiation of Treatment With a Prescription Digital Therapeutic for Chronic Insomnia: Two-year Follow up Analysis of Health Care Claims Data

Abstract: Objective: This study evaluated the 2-year effectiveness of the first FDA-authorized prescription digital therapeutic (PDT) for adults with chronic insomnia that delivers eviden...

Cyndi Patton Guinn ;

Samantha McStocker ;

01/19/2023

Effects of a Digital CBT-I Therapeutic in Improving Sleep and Reducing Anxiety and Depression Symptoms in Adults With Chronic Insomnia: Interim Analysis of DREAM Study

Abstract: Introduction: Chronic insomnia (CI) often co-occurs with depression and anxiety. This ongoing study collected real-world data on changes in insomnia, depression, and anxiety sym...

Cyndi Patton Guinn ;

Samantha McStocker ;

01/19/2023

Clinician Interaction With a Prescription Digital Therapeutic for OUD: Engagement and Outcomes

Abstract: Background: Prescription digital therapeutics (PDTs) are U.S. Food and Drug Administration-authorized software-based treatments delivered on mobile devices. The reSET-O PDT for ...

Maria Sullivan ;

Samantha McStocker ;

01/19/2023

Abstract: Aim: Prescription digital therapeutics (PDTs) are software-based treatments evaluated for safety and effectiveness by the FDA. This study evaluated associations between age and ...

Samantha McStocker ;

Maria Sullivan ;

01/19/2023

Advancing Health Equity: Evidence That a Prescription Digital Therapeutic for Opioid Use Disorder Enables Healthcare Access Across Geographic Regions

Abstract: Objectives: Between 80% and 90% of patients with opioid use disorder (OUD) do not receive behavioral treatments due, in part, to geographic barriers. This study evaluated assoc...

Audrey Kern ;

Samantha McStocker ;

01/19/2023